Fifth Third Bancorp
PRAX icon

Fifth Third Bancorp’s Praxis Precision Medicines PRAX Stock Holding History

Fifth Third Bancorp’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
6,359
+2,770
+77% +$877K ﹤0.01% 1231
2026
Q1 		$1.16M Buy
+3,589
New +$1.11M ﹤0.01% 1541

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fifth Third Bancorp's PRAX Position: Q2 2026 in Review

Fifth Third Bancorp increased its Praxis Precision Medicines (PRAX) stake by 77% in Q2 2026, buying an estimated $877K and bringing the position to 6,359 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

Fifth Third Bancorp first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Fifth Third Bancorp held 6,359 shares of Praxis Precision Medicines worth $2.13M as of Q2 2026.
  • Fifth Third Bancorp bought 2,770 Praxis Precision Medicines shares in Q2 2026, an estimated $877K.
  • Praxis Precision Medicines made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1231 holding.
  • Fifth Third Bancorp first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.